Karapanagiotou E - Search Results

1

Tuberculosis associated with Triplet therapy for lung cancer.

Crawley D, Breen RA, Elkington PT, Karapanagiotou E. Crawley D, et al. Among authors: karapanagiotou e. Thorax. 2020 Jul;75(7):609-610. doi: 10.1136/thoraxjnl-2019-213913. Epub 2020 May 14. Thorax. 2020. PMID: 32409610

2

Salvage pulmonary resection in stages IIIb-IV lung cancer after treatment with immune checkpoint inhibitors case series and literature review.

Smith A, Wali A, Montes A, Hadaki M, Harrison-Phipps K, Karapanagiotou EM, Bille A. Smith A, et al. Among authors: karapanagiotou em. J Surg Oncol. 2022 Feb;125(2):290-298. doi: 10.1002/jso.26691. Epub 2021 Sep 27. J Surg Oncol. 2022. PMID: 34569618 Review.

3

A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer.

Karapanagiotou EM, Charpidou A, Tzannou I, Dilana K, Kotteas E, Tourkantonis I, Kosmas E, Provata A, Syrigos K. Karapanagiotou EM, et al. Med Oncol. 2008;25(3):303-8. doi: 10.1007/s12032-007-9036-9. Epub 2008 Jan 17. Med Oncol. 2008. PMID: 18204976 Clinical Trial.

4

The need for third-line treatment in non-small cell lung cancer: an overview of new options.

Syrigos KN, Saif MW, Karapanagiotou EM, Oikonomopoulos G, De Marinis F. Syrigos KN, et al. Anticancer Res. 2011 Feb;31(2):649-59. Anticancer Res. 2011. PMID: 21378351 Review.

5

Therapy-induced toxicity of the lungs: an overview.

Charpidou AG, Gkiozos I, Tsimpoukis S, Apostolaki D, Dilana KD, Karapanagiotou EM, Syrigos KN. Charpidou AG, et al. Anticancer Res. 2009 Feb;29(2):631-9. Anticancer Res. 2009. PMID: 19331213 Free article. Review.

6

Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.

Miles A, Evans RE, Halligan S, Beare S, Bridgewater J, Goh V, Janes SM, Navani N, Oliver A, Morton A, Morris S, Rockall A, Taylor SA; STREAMLINE investigators. Miles A, et al. J Med Imaging Radiat Oncol. 2020 Aug;64(4):537-545. doi: 10.1111/1754-9485.13038. Epub 2020 May 14. J Med Imaging Radiat Oncol. 2020. PMID: 32410378 Free PMC article.

7

Carboplatin-pemetrexed adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): a phase II study.

Karapanagiotou EM, Boura PG, Papamichalis G, Konstantinou M, Sepsas E, Chamalakis G, Simsiris P, Gkiozos I, Syrigos KN. Karapanagiotou EM, et al. Anticancer Res. 2009 Oct;29(10):4297-301. Anticancer Res. 2009. PMID: 19846990 Free article. Clinical Trial.

8

Erlotinib-induced skin rash in patients with non-small-cell lung cancer: pathogenesis, clinical significance, and management.

Tsimboukis S, Merikas I, Karapanagiotou EM, Saif MW, Syrigos KN. Tsimboukis S, et al. Clin Lung Cancer. 2009 Mar;10(2):106-11. doi: 10.3816/CLC.2009.n.013. Clin Lung Cancer. 2009. PMID: 19362953 Review.

9

Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients.

Karapanagiotou EM, Polyzos A, Dilana KD, Gratsias I, Boura P, Gkiozos I, Syrigos KN. Karapanagiotou EM, et al. Lung Cancer. 2009 Dec;66(3):393-8. doi: 10.1016/j.lungcan.2009.02.006. Epub 2009 Mar 17. Lung Cancer. 2009. PMID: 19282046

10

Rapid infusion of ibandronate in lung cancer patients with bone metastases.

Kiagia M, Karapanagiotou E, Charpidou A, Dilana K, Dionellis G, Dannos I, Georgiou E, Syrigos KN. Kiagia M, et al. Among authors: karapanagiotou e. Anticancer Res. 2006 Jul-Aug;26(4B):3133-6. Anticancer Res. 2006. PMID: 16886646 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page